Anisa, 25, who is of Somali heritage, said her 'whole world stopped' when she was diagnosed - now she shares her story to help other Gen Z women and those from minority backgrounds ...

The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain lesions, might be warranted, reported Kamran Ahmed, MD, of Moffitt Cancer Center ...

A far shorter, simpler, and less toxic treatment protocol for patients with triple-negative breast cancer produced outcomes ...

A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study, published in ...

Triple-negative breast cancer (TNBC) has long been one of the most difficult forms of breast cancer to treat. Unlike other breast cancer subtypes, TNBC lacks estrogen, progesterone, and HER2 ...

Leukemia symptoms can vary by the cancer stage and type of leukemia you have. In the early stages, leukemia symptoms like fatigue, fever, and bruising can be subtle and easily dismissed. But, as the ...

While triple-negative breast cancer may be more aggressive than hormone receptor-positive breast cancer, it may also be more curable. Family history is a risk factor for breast cancer. A number of ...

She says: “Cervical cancer may not have obvious symptoms in the early stages ... “If the result is negative, the cell sample will be discarded and you will be called for your next routine ...

In a TikTok that’s racked up 2.3 million views, Radwah Oda — who is now battling stage 4 colon cancer while working at her office job — broke down the five symptoms she ignored and explained ...

In pancreatic cancer, symptoms are unclear and often emerge ... potential of the ADC when it comes to other cancers, e.g., triple-negative breast cancer and colon cancer, with a pressing need ...

Nearly 75% of women treated with a novel vaccine designed to prevent triple-negative breast cancer achieved an immune response, according to updated results of a phase 1 trial. Injection site ...